Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Vekemans

Showing results (11-20 of 115) with videos related to

Pageof 12
Sort By:
Vaccine|March 7, 2017
Report from the World Health Organization's third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8-10th June 2016Birgitte K Giersing, Johan Vekemans, Samantha Nava, et al.
The European Respiratory Journal|March 22, 2020
The case for assessing the full value of new tuberculosis vaccinesNebiat Gebreselassie, Raymond Hutubessy, Johan Vekemans, et al.
F1000Research|November 19, 2019
Vaccine impact on antimicrobial resistance to inform Gavi, the Vaccine Alliance's 2018 Vaccine Investment Strategy: report from an expert surveyMaya Malarski, Mateusz Hasso-Agopsowicz, Adam Soble, et al.
Vaccine|March 18, 2017
Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25-26 April 2016Birgitte K Giersing, Ruth A Karron, Johan Vekemans, et al.
The Lancet. Global Health|November 12, 2019
Potential effect of age of BCG vaccination on global paediatric tuberculosis mortality: a modelling studyPartho Roy, Johan Vekemans, Andrew Clark, et al.
Human Vaccines|November 24, 2011
Pooled analysis of safety data from pediatric Phase II RTS,S/AS malaria candidate vaccine trialsJohan Vekemans, Yolanda Guerra, Marc Lievens, et al.
Revista Da Sociedade Brasileira De Medicina Tropical|February 18, 2006
[Immune responses of non-infected neonates of mothers infected with Trypanosoma cruzi]Carine Truyens, Emmanuel Hermann, Cristina Alonso-Vega, et al.
F1000Research|November 3, 2016
Group B <i>Streptococcus</i> vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countriesMiwako Kobayashi, Johan Vekemans, Carol J Baker, et al.
Vaccine|March 3, 2018
WHO/IVI global stakeholder consultation on group A Streptococcus vaccine development: Report from a meeting held on 12-13 December 2016Joshua Osowicki, Johan Vekemans, David C Kaslow, et al.
Plos One|January 10, 2013
A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01EFrancis M Ndungu, Jedidah Mwacharo, Domtila Kimani, et al.
Pageof 12

Showing results (11-20 of 115) with videos related to

Sort By:
Pageof 12
Vaccine|March 7, 2017
Report from the World Health Organization's third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8-10th June 2016Birgitte K Giersing, Johan Vekemans, Samantha Nava, et al.
The European Respiratory Journal|March 22, 2020
The case for assessing the full value of new tuberculosis vaccinesNebiat Gebreselassie, Raymond Hutubessy, Johan Vekemans, et al.
F1000Research|November 19, 2019
Vaccine impact on antimicrobial resistance to inform Gavi, the Vaccine Alliance's 2018 Vaccine Investment Strategy: report from an expert surveyMaya Malarski, Mateusz Hasso-Agopsowicz, Adam Soble, et al.
Vaccine|March 18, 2017
Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25-26 April 2016Birgitte K Giersing, Ruth A Karron, Johan Vekemans, et al.
The Lancet. Global Health|November 12, 2019
Potential effect of age of BCG vaccination on global paediatric tuberculosis mortality: a modelling studyPartho Roy, Johan Vekemans, Andrew Clark, et al.
Human Vaccines|November 24, 2011
Pooled analysis of safety data from pediatric Phase II RTS,S/AS malaria candidate vaccine trialsJohan Vekemans, Yolanda Guerra, Marc Lievens, et al.
Revista Da Sociedade Brasileira De Medicina Tropical|February 18, 2006
[Immune responses of non-infected neonates of mothers infected with Trypanosoma cruzi]Carine Truyens, Emmanuel Hermann, Cristina Alonso-Vega, et al.
F1000Research|November 3, 2016
Group B <i>Streptococcus</i> vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countriesMiwako Kobayashi, Johan Vekemans, Carol J Baker, et al.
Vaccine|March 3, 2018
WHO/IVI global stakeholder consultation on group A Streptococcus vaccine development: Report from a meeting held on 12-13 December 2016Joshua Osowicki, Johan Vekemans, David C Kaslow, et al.
Plos One|January 10, 2013
A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01EFrancis M Ndungu, Jedidah Mwacharo, Domtila Kimani, et al.
Pageof 12